Portolan Capital Management, LLC Haemonetics Corp Transaction History

Portolan Capital Management, LLC

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$75.65 - $93.58 $2.02 Million - $2.5 Million
-26,747 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$84.96 - $118.91 $53,099 - $74,318
625 Added 2.39%
26,747 $2.4 Million
Q1 2020

May 14, 2020
BUY
$74.34 - $121.82 $1.94 Million - $3.18 Million
26,122 New
26,122 $2.6 Million

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.3B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email